Key result
Minimally invasive prostatectomy was associated with a lower risk of iatrogenic complications compared to open surgery in the late period (OR 0.72; 95% CI 0.61-0.86).
Why the study?
Does minimally invasive prostatectomy reduce iatrogenic complications and length of stay compared to open prostatectomy in patients with prostate cancer?
Cohort (n=776,366)
Yes
Does minimally invasive prostatectomy reduce iatrogenic complications and length of stay compared to open prostatectomy in patients with prostate cancer?
Minimally invasive prostatectomy has become safer than open surgery over time, likely reflecting the overcoming of the surgical learning curve.
May favor minimally invasive prostatectomy after learning curve; extends observational data but leaves open randomized confirmation and length-of-stay effects.
OBJECTIVE: To assess national trends of iatrogenic complications and associated burden of care among patients undergoing open and minimally invasive prostatectomy using a population-based cohort. METHODS: Using the nationally representative cohort, we identified patients who were diagnosed with prostate cancer, and underwent prostatectomy during 2001 and 2011. We determined the risk of iatrogenic complication and length of stay (LOS) over time among open and minimally invasive surgery (MIS) patients. Hierarchical multivariable logistic regression was performed to assess the changes over time and elucidate independent predictors of iatrogenic complications. RESULTS: We identified 556,932 and 219,434 prostate cancer patients undergoing open and minimally invasive prostatectomy. We found that iatrogenic complications for MIS were less frequent in later years (years 09-11 vs. year 01-02 odds ratio (OR), 0.21; 95% confidence intervals (CI), 0.09-0.40). MIS was associated with higher risk of iatrogenic complications in early period (years 01-02 OR, 3.81; 95% CI, 1.72-8.41), but lower risk in late period (years 09-11 OR 0.72 95% CI 0.61-0.86). Patients who experienced iatrogenic complications tended to have longer LOS (Median: Open vs. MIS, 4 days vs. 3 day) than those who didn't (Median: Open vs. MIS, 2 days vs. 1 day), regardless of procedure type. CONCLUSION: We found that minimally invasive prostatectomy is associated with lower risk of iatrogenic complications when compared with open surgery (OS). However, as "learning curve" is overcome over time, MIS becomes safer than OS. Iatrogenic complications are not benign and seem to be associated with higher burden of inpatient care.
No takes yet. Share an insight, caveat, or question.
Chughtai et al. (2014) conducted a cohort in Prostate cancer (n=776,366). Minimally invasive prostatectomy vs. Open prostatectomy was evaluated on Iatrogenic complications (OR 0.72, 95% CI 0.61-0.86). Minimally invasive prostatectomy was associated with a lower risk of iatrogenic complications compared to open surgery in the late period (OR 0.72; 95% CI 0.61-0.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: